| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...876990C |
| P356 | DOI | 10.1371/JOURNAL.PONE.0076990 |
| P932 | PMC publication ID | 3800077 |
| P698 | PubMed publication ID | 24204719 |
| P5875 | ResearchGate publication ID | 258350702 |
| P50 | author | Leif Kofoed Nielsen | Q55100176 |
| Morten Hanefeld Dziegiel | Q55100179 | ||
| Ann Tabor | Q55362953 | ||
| Frederik B. Clausen | Q42327851 | ||
| P2093 | author name string | Grethe Risum Krog | |
| Klaus Rieneck | |||
| Tanja Roien Jakobsen | |||
| P2860 | cites work | Effect of formaldehyde treatment on the recovery of cell-free fetal DNA from maternal plasma at different processing times. | Q50457564 |
| Study of compliance with a new, targeted antenatal D immunization prevention programme in Denmark. | Q50556010 | ||
| Quantity versus quality: optimal methods for cell-free DNA isolation from plasma of pregnant women. | Q51109942 | ||
| An international reference reagent for the detection of RHD and SRY DNA in plasma. | Q51406742 | ||
| A new methodology to preserve the original proportion and integrity of cell-free fetal DNA in maternal plasma during sample processing and storage. | Q53334658 | ||
| Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. | Q54301772 | ||
| Cell-free fetal DNA in specimen from pregnant women is stable up to 5 days. | Q54342228 | ||
| Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation. | Q54393922 | ||
| The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. | Q54520641 | ||
| Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. | Q54688617 | ||
| Earliest gestational age for fetal sexing in cell-free maternal plasma. | Q54736349 | ||
| Prenatal genotyping of RHD and SRY using maternal blood. | Q54741354 | ||
| Workshop report on the extraction of foetal DNA from maternal plasma | Q56001878 | ||
| Fetal DNA detection in maternal plasma throughout gestation | Q56836344 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Cell-Free Fetal DNA in Maternal Plasma during Physiological Single Male Pregnancies: Methodology Issues and Kinetics | Q57557794 | ||
| Identifying mild and severe preeclampsia in asymptomatic pregnant women by levels of cell-free fetal DNA | Q61848062 | ||
| High levels of fetal DNA are associated with increased risk of spontaneous preterm delivery | Q61848064 | ||
| Determination of fetal RhD status by maternal plasma DNA analysis | Q73808672 | ||
| Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR | Q75244894 | ||
| Detection of fetal RHD-specific sequences in maternal plasma | Q77429872 | ||
| Fetal cell-free plasma DNA concentrations in maternal blood are stable 24 hours after collection: analysis of first- and third-trimester samples | Q78734317 | ||
| Evaluation of two real-time multiplex PCR screening assays detecting fetal RHD in plasma from RhD negative women to ascertain the requirement for antenatal RhD prophylaxis | Q82433028 | ||
| Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 | ||
| Implementing prenatal diagnosis based on cell-free fetal DNA: accurate identification of factors affecting fetal DNA yield | Q28744238 | ||
| A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma | Q33361680 | ||
| RhD haemolytic disease of the fetus and the newborn | Q33901403 | ||
| Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience | Q34192088 | ||
| From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges | Q34286705 | ||
| Recent advances in the prenatal interrogation of the human fetal genome | Q34312211 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Non-invasive antenatal RHD typing | Q36431820 | ||
| Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study | Q36538133 | ||
| Uses of cell free fetal DNA in maternal circulation | Q38006298 | ||
| Genomic analysis of fetal nucleic acids in maternal blood | Q38015501 | ||
| Variants of RhD--current testing and clinical consequences | Q38083742 | ||
| Cell-free fetal DNA and maternal serum analytes for monitoring embryonic and fetal status | Q38090127 | ||
| Noninvasive fetal blood grouping: present and future | Q39868111 | ||
| Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women. | Q40380350 | ||
| Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service | Q40626763 | ||
| Next-generation sequencing: proof of concept for antenatal prediction of the fetal Kell blood group phenotype from cell-free fetal DNA in maternal plasma | Q44639381 | ||
| Improvement in fetal DNA extraction from maternal plasma. Evaluation of the NucliSens Magnetic Extraction system and the QIAamp DSP Virus Kit in comparison with the QIAamp DNA Blood Mini Kit. | Q44779251 | ||
| Selection of the optimal manual method of cell free fetal DNA isolation from maternal plasma. | Q44912941 | ||
| Non-invasive prenatal determination of fetal sex: translating research into clinical practice | Q44982893 | ||
| Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis | Q46172895 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e76990 | |
| P577 | publication date | 2013-10-18 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Pre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHD | |
| P478 | volume | 8 |
| Q38550197 | Detecting cancer biomarkers in blood: challenges for new molecular diagnostic and point-of-care tests using cell-free nucleic acids |
| Q38178293 | Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis |
| Q36837125 | Fetal RHD Genotyping Using Real-Time Polymerase Chain Reaction Analysis of Cell-Free Fetal DNA in Pregnancy of RhD Negative Women in South of Iran. |
| Q40901636 | How to evaluate PCR assays for the detection of low-level DNA. |
| Q38178923 | Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care |
| Q55644557 | Non-invasive foetal RhD genotyping to guide anti-D prophylaxis: an external quality assurance workshop. |
| Q38618865 | Noninvasive Antenatal Determination of Fetal Blood Group Using Next-Generation Sequencing. |
| Q87466211 | Noninvasive fetal RhD genotyping |
| Q102331644 | Prenatal RHD genotyping in Croatia: preliminary results |
| Q100413944 | RhIg for the prevention Rh immunization and IVIg for the treatment of affected neonates |
| Q46227317 | Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark. |
| Q38563344 | Stability of cell-free DNA from maternal plasma isolated following a single centrifugation step |
| Q48339604 | Vox Sanguinis International Forum on application of fetal blood grouping. |
Search more.